[Plasmapheresis in systemic sclerosis and polymyositis/dermatomyositis].
Matsuda
Masayuki
M
Third Department of Medicine, Shinshu University School of Medicine.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000302:isolation & purification; D003131:Combined Modality Therapy; D003882:Dermatomyositis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010951:Plasma Exchange; D010956:Plasmapheresis / Q000379:methods*; D017285:Polymyositis / Q000209:etiology / Q000628:therapy*; D012595:Scleroderma, Systemic / Q000209:etiology / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D000974:Antibodies, Antinuclear; D007166:Immunosuppressive Agents